Alvesco

Product manufactured by Covis Pharma

Application Nr Approved Date Route Status External Links
NDA021658 None Respiratory (Inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Alvesco Is An Inhaled Corticosteroid Indicated For: Maintenance Treatment Of Asthma As Prophylactic Therapy In Adult And Adolescent Patients 12 Years Of Age And Older. ( 1 ) Alvesco Is Not Indicated For The Relief Of Acute Bronchospasm. ( 1 ) 1.1 Treatment Of Asthma Alvesco Is Indicated For The Maintenance Treatment Of Asthma As Prophylactic Therapy In Adult And Adolescent Patients 12 Years Of Age And Older. Important Limitations Of Use: Alvesco Is Not Indicated For The Relief Of Acute Bronchospasm. Alvesco Is Not Indicated For Children Under 12 Years Of Age.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ciclesonide CICLESONIDE ZINC3915154

Comments